GlassScriptPhysician profile
John A Gonzalez
NPI 1861490542
$1,539.92
in general payments reported to CMS, 2019-2025
20 companies · $95.99 in 2025
The $95.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $520 · 2020: $219 · 2021: $389 · 2022: $189 · 2023: $70.84 · 2024: $56.02 · 2025: $95.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.55 | 2019-2025 | |
| Avanos Medical | $216.36 | 2019 | |
| Hologic Sales and Service, LLC | $158.70 | 2019-2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Allergan, INC. | $141.76 | 2019-2022 | |
| Pfizer INC. | $131.83 | 2019-2021 | |
| Medtronic USA, INC. | $96.79 | 2019-2020 | |
| Coloplast Corp | $93.03 | 2019-2024 | |
| Coopersurgical, INC. | $84.16 | 2022-2025 | Ally II Ups |
| Astellas Pharma US INC | $72.82 | 2019-2022 | |
| Axonics, INC. | $49.14 | 2021-2022 | |
| Therapeuticsmd, INC. | $44.64 | 2019-2022 | |
| Amgen INC. | $30.18 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.84 | 2020-2022 | |
| Avion Pharmaceuticals | $26.93 | 2020-2021 | |
| Boston Scientific Corporation | $25.94 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $22.43 | 2019-2021 | |
| Duchesnay USA Incorporated | $21.12 | 2019 | |
| Novo Nordisk INC | $19.77 | 2023 | Wegovy |
| Lilly USA, LLC | $18.06 | 2021 | |
| Currax Pharmaceuticals LLC | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.